BriefCase-Triage vs Rapid Enterprise Platform
AI Verdict
Choose BriefCase-Triage if…
Choose BriefCase-Triage if your primary need is to rapidly detect and prioritize critical findings in medical images for workflow triage, particularly for time-sensitive conditions like intracranial hemorrhages, cervical spine fractures, or aortic dissections. This tool excels at flagging suspected positive findings to help radiologists prioritize cases and reduce turnaround times, enhancing diagnostic accuracy by reducing overlooked cases.
View BriefCase-Triage →Choose Rapid Enterprise Platform if…
Choose Rapid Enterprise Platform if you require a comprehensive, deep clinical AI solution that integrates across the entire health system, connecting imaging to clinical action for multiple disease states. This platform is ideal for organizations seeking to optimize care coordination, leverage advanced analytics for performance improvement, and utilize a full suite of neurocritical assessment tools, including solutions for ischemic stroke and aneurysms.
View Rapid Enterprise Platform →When choosing between BriefCase-Triage by Aidoc and Rapid Enterprise Platform by RapidAI, physicians should consider their primary focus and existing infrastructure. BriefCase-Triage excels in rapidly detecting and prioritizing critical findings across a broad range of medical images, offering a comprehensive triage solution for multiple indications within a single workflow. Its strength lies in streamlining radiology workflows with real-time alerts and a focus on reducing false positives, making it ideal for practices seeking to enhance overall imaging efficiency and critical case identification. Aidoc emphasizes a continuous learning model and offers flexible payment options, catering to a wide range of health system sizes.
The Rapid Enterprise Platform, conversely, provides deep clinical AI solutions that connect imaging to clinical action, particularly strong in neurocritical assessment and complete ischemic stroke solutions. While both are FDA-cleared and integrate with existing hospital systems, RapidAI’s platform offers a hybrid deployment option (cloud-first with on-premise capabilities), which might be a key practical difference for institutions with specific data residency or infrastructure preferences. RapidAI also highlights its full suite of neurocritical assessment tools and a dedicated AI interface for case prioritization (Navigator Pro), suggesting a more specialized and in-depth approach for neurology and critical care. Physicians prioritizing advanced, specialized insights, particularly in stroke and neurological conditions, and those requiring on-premise deployment flexibility, may find RapidAI’s platform more aligned with their needs.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | BriefCase-Triage | Rapid Enterprise Platform |
|---|---|---|
| Pricing | Enterprise | Unknown |
| Deployment | Cloud | Hybrid (cloud-first with on-premise capabilities), On-Premise, Cloud |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
| EHR Integration | Epic | Allscripts, athenahealth, cerner, Epic, harris-healthcare, MEDITECH |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TieBoth tools emphasize seamless integration with existing hospital systems like PACS and EHRs, and both offer mobile applications for care coordination. While Aidoc highlights a 'comprehensive triage solution' and 'order-of-magnitude reduction in false alerts,' RapidAI focuses on 'deep clinical AI' and an 'AI interface for case prioritization (Navigator Pro).' Without direct comparative user experience data, it's difficult to definitively pick a winner in usability.
Clinical Value
Rapid Enterprise PlatformRapidAI demonstrates superior clinical validation with over 700 publications, including landmark trials (DAWN, DEFUSE-3) that expanded stroke treatment guidelines. Aidoc also has numerous FDA clearances and studies showing reduced turnaround times and missed findings, but RapidAI's depth of evidence and impact on treatment guidelines give it an edge.
Pricing & Value
TieBoth companies utilize an enterprise pricing model, requiring direct contact for quotes based on institutional size, modules, and deployment scale. Aidoc's baseline pricing starts around $50,000 per site per year for 3-5 modules, with additional modules costing $8,000-$15,000. RapidAI's single module pricing starts at approximately $12,000. Given the variability in enterprise solutions, a direct comparison of overall value is not possible without specific use-case pricing.
Enterprise Readiness
Rapid Enterprise PlatformRapidAI has a larger customer base, deployed in over 2,500 hospitals across more than 100 countries, compared to Aidoc's 1,600+ hospitals worldwide. RapidAI also offers a hybrid deployment model (cloud-first with on-premise capabilities), providing greater flexibility for diverse health system IT infrastructures.
Innovation
Rapid Enterprise PlatformRapidAI emphasizes 'deep clinical AI' that goes beyond simple triage to characterize, quantify, visualize, and track changes over time, and has expanded its platform to manage other critical vascular and cardiac conditions. Aidoc also utilizes a 'Continuous learning model' and a 'Foundation Model AI' for comprehensive triage, but RapidAI's focus on in-depth analysis and broader disease state expansion appears to be a more significant innovative stride.
Support & Docs
Rapid Enterprise PlatformRapidAI explicitly states 24/7 customer support and offers extensive educational resources through 'Rapid U,' webinars, whitepapers, and a publication library of over 750 studies. While Aidoc mentions continuous learning and mobile app for care coordination, specific details on their support and documentation offerings are less comprehensive in the provided information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | BriefCase-Triage | Rapid Enterprise Platform |
|---|---|---|
| Name | BriefCase-Triage | Rapid Enterprise Platform |
| Company | Aidoc Medical | RapidAI |
| Mobile App | both | yes |
| API Available | yes | yes |
| Target Size | Solo to large health systems | Hospitals and Health Systems |
| Customer Count | 1,600+ hospitals worldwide | 2,500+ |
| Key Features | AI-powered analysis of medical imaging, Real-time alerts and notifications, Seamless integration with existing hospital systems (PACS, EHR), Prioritization of critical cases, Order-of-magnitude reduction in false alerts, Comprehensive triage solution (multiple indications in one workflow), Mobile app for care coordination, Continuous learning model | Deep clinical AI for advanced insights, Workflow integration with EHR, PACS, and other systems, Enterprise-grade security and compliance, Data and analytics for performance optimization, FDA-cleared AI across multiple body regions, Radiology's AI interface for case prioritization (Navigator Pro), Full suite of neurocritical assessment tools, Complete ischemic stroke solution |
Videos
Demos, reviews, and walkthroughs featuring BriefCase-Triage and Rapid Enterprise Platform.